The Board of Regents of the University of Wisconsin
Madison, Wisconsin 53792-6188
2 studies enrolling now · 3 studies all time
What they study most
Advanced Solid Tumor, Cancer, Duchenne Muscular Dystrophy
Studies at this site
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
- An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy — Enrolling by invitation
- Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors — Completed